MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioCryst Pharmaceuticals Company Profile (NASDAQ:BCRX)

Consensus Ratings for BioCryst Pharmaceuticals (NASDAQ:BCRX) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $17.00 (12.58% upside)

Current Analysts' Coverage Summary for BioCryst Pharmaceuticals (NASDAQ:BCRX)
Show:
DateFirmActionRatingPrice TargetActions
6/30/2015Bank of AmericaUpgradeNeutral -> Buy$12.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015FBR & Co.Initiated CoverageOutperform$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Needham & Company LLCSet Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014MLV & Co.Set Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Noble FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014JPMorgan Chase & Co.Lower Price TargetOverweight$20.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2014Wells Fargo & Co.UpgradeMarket Perform -> Outperform$19.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/30/2014HC WainrightBoost Price TargetBuy$21.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2014Roth CapitalBoost Price Target$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2014Brinson PatrickInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014Piper JaffrayInitiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014MizuhoInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2014JMP SecuritiesReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/4/2013 forward)